Genetic inactivation of Tmprss6 both in mice and human causes severe, atypical iron deficiency, characterized by microcytic anemia and inability to respond to oral iron treatment, because of inappropriately high hepcidin levels [8], [9], [10]. The gene discussed is HAMP; the disease is Iron deficiency anemia.